Indivior director granted 6,518 RSUs

Ryan Barbara reported acquisition or exercise transactions in this Form 4 filing.

Rhea-AI Filing Summary

Ryan Barbara reported acquisition or exercise transactions in this Form 4 filing.

Indivior Pharmaceuticals, Inc. director Ryan Barbara reported receiving a grant of 6,518 shares of common stock in the form of Restricted Stock Units (RSUs) at no cash cost. After this award, the director holds 12,242 common shares directly.

Each RSU represents a contingent right to receive one share of common stock and will vest on the day immediately before the next annual stockholder meeting, as long as the director continues to serve until that date. This is a compensation-related equity award rather than an open‑market purchase or sale.

Insider Trade Summary

Grant/Award: 6,518 shares

Grant/Award 1 txn

Insider Ryan Barbara

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	6,518	$0.00	$0.00

Holdings After Transaction: Common Stock — 12,242 shares (Direct)

Footnotes (1)

1. F1. Reflects a grant of Restricted Stock Units (RSUs). Each RSU represents a contingent right to receive one share of the Issuer's common stock. The RSUs vest on the day immediately preceding the date of the annual meeting of the Issuer's stockholders following the date of grant, subject to the Reporting Person's continued service to the Issuer on the vesting date.

Key Figures

RSU grant size: 6,518 shares Award price per share: $0.0000 per share Post‑transaction holdings: 12,242 shares +1 more

4 metrics

RSU grant size 6,518 shares Restricted Stock Units awarded to director on May 13, 2026

Award price per share $0.0000 per share Indicates no cash paid by director for RSU grant

Post‑transaction holdings 12,242 shares Total common shares reported following the RSU award

Transaction direction Acquisition (grant/award) Form 4 code A for grant, award, or other acquisition

Key Terms

Restricted Stock Units (RSUs), contingent right, vesting date, annual meeting of the Issuer's stockholders

4 terms

Restricted Stock Units (RSUs) financial

"Reflects a grant of Restricted Stock Units (RSUs). Each RSU represents a contingent right"

Restricted stock units (RSUs) are a type of company promise to give employees shares of stock in the future, usually after certain conditions like working for a set time. They are like a gift promised today that you receive later, which can become valuable if the company's stock price goes up. RSUs matter because they are a way companies reward employees and can be a significant part of compensation.

contingent right financial

"Each RSU represents a contingent right to receive one share of the Issuer's common stock."

vesting date financial

"The RSUs vest on the day immediately preceding the date of the annual meeting ... on the vesting date."

annual meeting of the Issuer's stockholders financial

"on the day immediately preceding the date of the annual meeting of the Issuer's stockholders"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Indivior (INDV) report in this Form 4?

Indivior reported that director Ryan Barbara received 6,518 Restricted Stock Units (RSUs). These RSUs are a stock-based compensation award, not an open-market trade, and each unit represents the right to receive one share of Indivior common stock upon vesting.

How many Indivior (INDV) shares does the director hold after this RSU grant?

Following the RSU grant, director Ryan Barbara is reported to hold 12,242 shares of Indivior common stock directly. This total includes the newly awarded 6,518 RSUs, which convert into shares when they vest under the terms of the grant.

Is the Indivior (INDV) Form 4 transaction a stock purchase or sale?

The Form 4 reports a stock award, not a purchase or sale. Director Ryan Barbara received 6,518 RSUs as compensation at no cash cost, so there was no open-market buying or selling involved in this transaction.

When do the newly granted Indivior (INDV) RSUs vest for the director?

The 6,518 RSUs vest on the day immediately before the next annual meeting of Indivior stockholders. Vesting depends on the director’s continued service to the company through that vesting date, according to the award’s terms.

What exactly is an RSU in the context of Indivior (INDV) stock awards?

An RSU, or Restricted Stock Unit, is a promise to deliver one share of stock upon vesting. For Indivior, each RSU granted to director Ryan Barbara becomes one share of common stock if the vesting conditions, including continued service, are satisfied.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 05/14/2026 - 04:07 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Ryan Barbara

(Last) (First) (Middle)

10710 MIDLOTHIAN TURNPIKE

SUITE 125

(Street)

NORTH CHESTERFIELD VIRGINIA 23235

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Indivior Pharmaceuticals, Inc. [ INDV ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/13/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	05/13/2026		A		6,518(1)	A	$0	12,242	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Reflects a grant of Restricted Stock Units (RSUs). Each RSU represents a contingent right to receive one share of the Issuer's common stock. The RSUs vest on the day immediately preceding the date of the annual meeting of the Issuer's stockholders following the date of grant, subject to the Reporting Person's continued service to the Issuer on the vesting date.

Remarks:

	/s/Alice Givens, Power of Attorney	05/14/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)